BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Symbotic, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm
September 21, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ZoomInfo Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZI
September 21, 2024 16:24 ET | The Rosen Law Firm PA
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of ZoomInfo Technologies, Inc. (NASDAQ: ZI) between...
BFA Logo Transparent (002).png
EXTR INVESTOR UPDATE: Extreme Networks, Inc. Investors that Lost Money are Notified to Contact BFA Law before October 15 Class Action Deadline (Nasdaq:EXTR)
September 21, 2024 07:18 ET | Bleichmar Fonti & Auld
Extreme Networks, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 15, 2024 legal deadline.
Sanofi new_logo.jpg
Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué (...)
September 20, 2024 18:36 ET | Sanofi - Aventis Groupe
Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué, non éligibles à...
Sanofi new_logo.jpg
Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant
September 20, 2024 18:36 ET | Sanofi - Aventis Groupe
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant         ...
DEADLINE ALERT for LULU, F, XPEL, EXTR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
September 20, 2024 13:50 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
LEM_Logo_Horizontal.png
LEADING EDGE REPORTS QUARTERLY RESULTS TO JULY 31, 2024
September 20, 2024 13:00 ET | Leading Edge Materials Corp.
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2024 Vancouver, September 20, 2024– Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for WBTN, ZI, and GTLB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
September 20, 2024 12:07 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
TIP_link_300x300.jpg
Digital English Language Learning Market Worth $15.03 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
September 20, 2024 10:36 ET | The Insight Partners
US & Canada, Sept. 20, 2024 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the tremendous progress in the information and communication technology (ICT)...
download.jpg
Extreme Networks (EXTR) Tumbled 18% After Guiding For Year-Over-Year Revenue Declines, Stock Has Not Recovered - Hagens Berman
September 20, 2024 10:14 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Extreme Networks, Inc. (NASDAQ: EXTR) investors who suffered substantial losses to submit your losses now. The firm also...